Delivery Order SPE2DE24D0021-SPE2D626F08Y4
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $4,904.90 by the Medical Supply Chain, a defense-focused federal agency, on September 25, 2025. The contract, designated as PRCRPLX MS CYTOKINE + CH 96 TS, involves the provision of specialized laboratory supplies—specifically cytokine and immunochemistry reagents and testing solutions. Structured as a fixed-price delivery order with economic price adjustment provisions, the contract has no set-aside designation,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $29,429.40 for procurement of cytokine and related testing supplies under a fixed-price contract with economic price adjustment provisions. The contract, issued on August 20, 2025, with an ultimate completion date of August 28, 2025, supports the Medical Supply Chain within the Department of Defense. Performance will be executed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $34,334.30 on July 30, 2025, for procurement of cytokine reagents and related testing supplies under a fixed-price contract with economic price adjustment provisions. This child contract, which has no set-aside designation, is funded by the Defense Department's Medical Supply Chain organization and specifies performance in Pittsburgh, Pennsylvania, with an ultimate completion date of August 7, 2025. As a major federal...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $34,334.30 on August 22, 2025, by the Medical Supply Chain, a defense-focused federal agency. The delivery order, designated as "PRCRPLX MS CYTOKINE + CH 96 TS," procures specialized cytokine and chemistry testing supplies for performance at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of September 2, 2025. This award represents a child contract under a...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 28, 2025, by the Department of Defense Medical Supply Chain for the procurement of Anti-Human Bioclone Reagent Grade 10 milliliter packages (15 per pack) with a ceiling value of $1,169.39. This is a fixed-price contract with economic price adjustment provisions, with performance to be completed by September 19, 2025, at the vendor's location in Pittsburgh, Pennsylvania. The award represents a child contract under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract (4570254179) valued at $4,732.86 for Hybridoma SFM (serum-free medium) by the Department of Defense's Medical Supply Chain on December 11, 2025. The contract utilizes fixed-price pricing with economic price adjustment provisions and is scheduled for completion by December 26, 2025. The work will be performed in Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of business. This delivery order...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $34,334.30 by the Medical Supply Chain, a defense-focused federal agency, on June 16, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of process complex mass cytokine and channel 96 test supplies to support operations at the agency's Pittsburgh, Pennsylvania facility. The award was made through open competition with no set-aside designation,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,560.94 by the Department of Defense's Medical Supply Chain division for the procurement of ANDI-D Bioclone 10ML in 15-pack quantities. This fixed-price delivery order with economic price adjustment authority was awarded without set-aside designation on August 1, 2025, and is scheduled for ultimate completion by August 22, 2025. The product will be delivered to Pittsburgh, PA 15275. This delivery order represents a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,167.00 by the Department of Defense's Medical Supply Chain for RGT RT PCR ROX AGPATH-ID ARRAYSCRIPT AMP diagnostic products. Awarded on November 5, 2025, with an ultimate completion date of November 21, 2025, this fixed-price contract with economic price adjustment represents a child order under a larger procurement vehicle. The award carries no set-aside designation, indicating Fisher Scientific competed in an...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,022.50 on August 19, 2025, by the Medical Supply Chain division of the Defense Department. The contract, which employs fixed-price pricing with economic price adjustment terms, calls for the delivery of 3AS HCG STAT 10MIU ULTRA 30/pack units to support operations in Pittsburgh, Pennsylvania. The delivery order is expected to conclude by August 22, 2025. This award represents a child contract under a larger vehicle and was...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F08Y4Delivery Order
Fisher Scientific Company L.L.C. has been awarded a fixed-price delivery order with economic price adjustment for GIBCO Human GM-CSF Recombinant Protein, valued at $9,210.00, with an ultimate completion date of December 29, 2025. The award was issued on December 11, 2025, by the Department of Defense's Medical Supply Chain as a child contract with no set-aside designation. The product will be delivered to Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of business. This delivery order represents a routine procurement of specialized laboratory and medical supplies that aligns with Fisher Scientific's extensive federal contracting portfolio supporting scientific research and healthcare delivery across multiple government departments. This award demonstrates Fisher Scientific's continued role as a major federal vendor for laboratory products and medical supplies. The company maintains an established presence with the Defense Department's Medical Supply Chain and benefits from pre-competed pricing arrangements, likely through existing indefinite delivery vehicles or General Services Administration schedules. Fisher Scientific's demonstrated capacity to supply specialized reagents and diagnostic equipment across federal agencies, including the Department of Veterans Affairs and various National Institutes of Health components, positions it as a reliable supplier for the recombinant protein procurement under this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 12/10/25 |